Literature DB >> 17229831

In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter spp.

Neil Woodford, Robert L R Hill, David M Livermore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17229831     DOI： 10.1093/jac/dkl514

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Susceptibility of common aerobic pathogens to tigecycline: results of a surveillance study in Germany.

Authors:  M Kresken; E Leitner; J Brauers; H K Geiss; E Halle; C von Eiff; G Peters; H Seifert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-21       Impact factor: 3.267

2.  Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness.

Authors:  Jeffrey Baron; Shuntao Cai; Natalie Klein; Burke A Cunha
Journal:  J Clin Med       Date:  2018-03-09       Impact factor: 4.241

3.  Acquisition of Tigecycline Resistance by Carbapenem-Resistant Klebsiella pneumoniae Confers Collateral Hypersensitivity to Aminoglycosides.

Authors:  Hua-le Chen; Yan Jiang; Mei-Mei Li; Yao Sun; Jian-Ming Cao; Cui Zhou; Xiao-Xiao Zhang; Yue Qu; Tie-Li Zhou
Journal:  Front Microbiol       Date:  2021-07-02       Impact factor: 5.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.